Common Aging Signature in the Peripheral Blood of Vascular Dementia and Alzheimer's Disease

被引:11
|
作者
Luo, Hongbo [1 ]
Han, Guangchun [2 ]
Wang, Jiajia [2 ,3 ]
Zeng, Fan [4 ,5 ]
Li, Yuanming [1 ]
Shao, Shaoju [1 ]
Song, Fuhai [2 ,3 ]
Bai, Zhouxian [2 ,3 ]
Peng, Xing [2 ,3 ]
Wang, Yan-Jiang [4 ,5 ]
Shi, Xiangqun [1 ]
Lei, Hongxing [2 ,6 ]
机构
[1] Lanzhou Mil Area Command, Lanzhou Gen Hosp, Dept Neurol, Lanzhou 730050, Gansu, Peoples R China
[2] Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genome Sci & Informat, Beijing 100101, Peoples R China
[3] Univ Chinese Acad Sci, Beijing 100049, Peoples R China
[4] Third Mil Med Univ, Daping Hosp, Dept Neurol, Chongqing 100053, Peoples R China
[5] Third Mil Med Univ, Daping Hosp, Ctr Clin Neurosci, Chongqing 100053, Peoples R China
[6] Beijing Inst Brain Disorders, Ctr Alzheimers Dis, Beijing 100053, Peoples R China
关键词
Vascular dementia; Alzheimer's disease; Peripheral blood; Gene expression; Ribosome; CORONARY-ARTERY-DISEASE; MILD COGNITIVE IMPAIRMENT; GENE-EXPRESSION PATTERNS; WHOLE-BLOOD; RATING-SCALE; RISK-FACTORS; S100A12; MARKER; METAANALYSIS; METABOLISM;
D O I
10.1007/s12035-015-9288-x
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Alzheimer's disease (AD) and vascular dementia (VaD) are the two most dominant forms of dementia in elderly people. Due to the large overlap between AD and VaD in clinical observations, great controversies exist regarding the distinction and connection between these two types of senile dementia. Here for the first time, we resort to the gene expression pattern of the peripheral blood to compare AD and VaD objectively. In our previous work, we have demonstrated that the dysregulation of gene expression in AD is unique among the examined diseases including neurological diseases, cancer, and metabolic diseases. In this study, we found that the dysregulation of gene expression in AD and VaD is quite similar to each other at both functional and gene levels. Interestingly, the dysregulation started at the early stages of the diseases, namely mild cognitive impairment (MCI) and vascular cognitive impairment (VCI). We have also shown that this signature is distinctive from that of peripheral vascular diseases. Comparison with aging studies revealed that the most profound change in AD and VaD, namely ribosome, is consistent with the accelerated aging scenario. This study may have implications to the common mechanism between AD and VaD.
引用
收藏
页码:3596 / 3605
页数:10
相关论文
共 50 条
  • [41] Peripheral immune system in aging and Alzheimer's disease
    Cao, Wei
    Zheng, Hui
    MOLECULAR NEURODEGENERATION, 2018, 13
  • [42] Gout and risk of dementia, Alzheimer's disease or vascular dementia: a meta-epidemiology study
    Li, Xuanlin
    Huang, Lin
    Tang, Yujun
    Hu, Xuanming
    Wen, Chengping
    FRONTIERS IN AGING NEUROSCIENCE, 2023, 15
  • [43] Alzheimer's/Vascular Spectrum Dementia: Classification in Addition to Diagnosis
    Emrani, Sheina
    Lamar, Melissa
    Price, Catherine C.
    Wasserman, Victor
    Matusz, Emily
    Au, Rhoda
    Swenson, Rodney
    Nagele, Robert
    Heilman, Kenneth M.
    Libon, David J.
    JOURNAL OF ALZHEIMERS DISEASE, 2020, 73 (01) : 63 - 71
  • [44] Vascular Risk Factors and Neurodegeneration in Ageing Related Dementias: Alzheimer's Disease and Vascular Dementia
    Akinyemi, Rufus O.
    Mukaetova-Ladinska, Elizabeta B.
    Attems, Johannes
    Ihara, Masafumi
    Kalaria, Raj N.
    CURRENT ALZHEIMER RESEARCH, 2013, 10 (06) : 642 - 653
  • [45] Association of Peripheral Blood Cell Profile With Alzheimer's Disease: A Meta-Analysis
    Huang, Le-Tian
    Zhang, Cheng-Pu
    Wang, Yi-Bing
    Wang, Jia-He
    FRONTIERS IN AGING NEUROSCIENCE, 2022, 14
  • [46] Alterations of amino acids in older adults with Alzheimer's Disease and Vascular Dementia
    Ma, Xin
    Wang, Xin-Meng
    Tang, Guo-Zhang
    Wang, Yi
    Liu, Xue-Chun
    Wang, Shuai-Deng
    Peng, Peng
    Qi, Xiu-Hong
    Qin, Xin-Ya
    Wang, Yue-Ju
    Wang, Chen-Wei
    Zhou, Jiang-Ning
    AMINO ACIDS, 2025, 57 (01)
  • [47] Neuropsychiatric Symptoms and Functional Status in Alzheimer's Disease and Vascular Dementia Patients
    D'Onofrio, Grazia
    Sancarlo, Daniele
    Panza, Francesco
    Copetti, Massimiliano
    Cascavilla, Leandro
    Paris, Francesco
    Seripa, Davide
    Matera, Maria G.
    Solfrizzi, Vincenzo
    Pellegrini, Fabio
    Pilotto, Alberto
    CURRENT ALZHEIMER RESEARCH, 2012, 9 (06) : 759 - 771
  • [48] CSF proteomic signature predicts progression to Alzheimer's disease dementia
    Vromen, Eleonora M.
    del Campo Milan, Marta
    Scheltens, Philip
    Teunissen, Charlotte E.
    Visser, Pieter Jelle
    Tijms, Betty M.
    ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS, 2022, 8 (01)
  • [49] Cardiovascular and metabolic comorbidities in patients with Alzheimer's disease and vascular dementia compared to a psychiatric control cohort
    Vogelgsang, Jonathan
    Wolff-Menzler, Claus
    Kis, Bernhard
    Abdel-Hamid, Mona
    Wiltfang, Jens
    Hessmann, Philipp
    PSYCHOGERIATRICS, 2018, 18 (05) : 393 - 401
  • [50] Cerebrovascular hemodynamics in Alzheimer's disease and vascular dementia: A meta-analysis of transcranial Doppler studies
    Sabayan, Behnam
    Jansen, Steffy
    Oleksik, Anna M.
    van Osch, Matthias J. P.
    van Buchem, Mark A.
    van Vliet, Peter
    de Craen, Anton J. M.
    Westendorp, Rudi G. J.
    AGEING RESEARCH REVIEWS, 2012, 11 (02) : 271 - 277